Medexus Pharmaceuticals Inc (MDP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,571 | 8,137 | 10,199 | 18,704 | 9,351 |
| Receivables | 14,689 | 14,083 | 17,037 | 18,829 | 26,122 |
| Inventories | 16,176 | 14,408 | 13,081 | 14,667 | 13,125 |
| Other current assets | 1,511 | 1,344 | 1,402 | 1,665 | 1,431 |
| TOTAL | $46,595 | $43,918 | $47,886 | $58,571 | $56,994 |
| Non-Current Assets | |||||
| PPE Net | 1,252 | 1,336 | 1,407 | 795 | 870 |
| Intangibles | 88,538 | 89,853 | 91,545 | 87,015 | 78,090 |
| Other Non-Current Assets | 1,746 | 2,103 | 2,132 | 2,132 | 2,116 |
| TOTAL | $91,536 | $93,292 | $95,084 | $89,942 | $81,076 |
| Total Assets | $138,131 | $137,210 | $142,970 | $148,513 | $138,049 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 18,231 | 12,860 | 16,375 | 10,569 | 17,025 |
| Accounts payable and accrued liabilities | 24,307 | 26,926 | 23,319 | 14,855 | 28,127 |
| Accrued Expenses | N/A | 2,647 | 658 | 12,575 | 651 |
| Other current liabilities | 3,132 | N/A | N/A | N/A | N/A |
| TOTAL | $46,639 | $43,075 | $42,299 | $39,937 | $48,025 |
| Non-Current Liabilities | |||||
| Long Term Debt | 34,766 | 34,532 | 35,331 | 34,303 | 33,545 |
| Other Non-Current Liabilities | 33,584 | 35,607 | 51,234 | 53,610 | 45,976 |
| TOTAL | $68,350 | $70,145 | $89,198 | $90,558 | $85,719 |
| Total Liabilities | $114,989 | $113,220 | $131,497 | $130,495 | $133,743 |
| Shareholders' Equity | |||||
| Common Shares | 68,668 | 67,776 | 66,752 | 66,688 | 47,212 |
| Retained earnings | -59,962 | -58,812 | -68,957 | -62,370 | -49,890 |
| Other shareholders' equity | 4,301 | 4,330 | 3,597 | 4,203 | -979 |
| TOTAL | $23,142 | $23,990 | $11,473 | $18,018 | $4,306 |
| Total Liabilities And Equity | $138,131 | $137,210 | $142,970 | $148,513 | $138,049 |